Global Genitourinary Collaboration and Licensing Agreement Analysis Report 2023: Breakdown by Company A-Z, Therapy Focus and Technology Type and Access to Upfront, Milestone, Royalties Data
November 17, 2023 06:03 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Genitourinary Collaboration and Licensing Deals 2016-2023" report has been added to ResearchAndMarkets.com's offering.Genitourinary Collaboration and...
Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)
October 23, 2023 07:03 ET
|
Unicycive Therapeutics, Inc.
- Pivotal clinical trial expected to initiate before year end - LOS ALTOS, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology...
US Nephrologists Embrace Current IgA Nephropathy Therapies, Yet a Thriving Pipeline Signals Fierce Market Evolution Ahead
October 13, 2023 14:24 ET
|
Spherix Global Insights
Exton, Pennsylvania, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The FDA's recent approvals of Calliditas' Tarpeyo (budesonide) and Travere's Filspari (sparsentan) to treat primary IgA nephropathy (IgAN) have...
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series
August 29, 2023 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023 17:36 ET
|
Unicycive Therapeutics, Inc.
Recent Data Publications Highlight the Benefits of Oxylanthanum Carbonate (OLC) to Improve Medication Adherence and Quality of Life for Patients with Chronic Kidney Disease Feedback from FDA...
Akebia’s Vafseo (vadadustat) Poised to Make Waves for GSK’s Jesduvroq and FibroGen/Astellas’ Evrenzo
July 20, 2023 15:07 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD) patients....
Travere Therapeutics Announces Interim Analysis from the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Published in The Lancet and Presented at World Congress of Nephrology 2023
April 01, 2023 04:30 ET
|
Travere Therapeutics, Inc.
SAN DIEGO, April 01, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced publication in The Lancet of the interim analysis of efficacy and safety data from the ongoing...
Panoramic Health Solidifies Position as Largest Physician-Led Participant in Medicare's Kidney Care Choices Model
January 24, 2023 11:00 ET
|
Panoramic Health
TEMPE, Ariz., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Panoramic Health℠, the leading integrated value-based kidney care platform in the country, announced significant growth as a participant in Medicare's...
Panoramic Health Expands Executive Management With Three Key Appointments
December 08, 2022 12:01 ET
|
Panoramic Health
TEMPE, Ariz., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Panoramic Health℠, the leading integrated value-based kidney care platform in the U.S., continues its expansion and growth delivering better outcomes...
In-Vitro Diagnostics Market Size & Share | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research
November 15, 2022 06:00 ET
|
Graphical Research
Pune, India, Nov. 15, 2022 (GLOBE NEWSWIRE) -- The global in-vitro diagnostics market size is expected to witness remarkable growth during the forecast period, attributed to growing incidence of...